6533b858fe1ef96bd12b59ab
RESEARCH PRODUCT
Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.
Salvatore ProvenzanoSilvana PilottiGiuseppe BadalamentiVittoria ColiaCarlo MorosiGianpaolo DagradaBruno VincenziAngelo Paolo Dei TosSilvia StacchiottiRossella BertulliPaolo G. CasaliMaristella SaponaraMichela Libertinisubject
OncologyCancer Researchmedicine.medical_specialtyChemotherapySolitary fibrous tumorSeries (stratigraphy)Anthracyclinebusiness.industrymedicine.medical_treatmentfungifood and beverages.medicine.diseaseOncologyInternal medicineMedicineDoxorubicinDacarbazine - DTICbusinessTrabectedinmedicine.drugdescription
11042Background: The reported response rate to chemotherapy (CT) in SFT is low both with anthracycline-based regimens ( ≤ 20%) and with trabectedin ( < 10%). DTIC can be active. We report on the co...
year | journal | country | edition | language |
---|---|---|---|---|
2016-05-20 | Journal of Clinical Oncology |